Abiopharma

News list

IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)

SEC News
June 17, 2025, 21:30 UTC

New Form SCHEDULE 13D/A - Enliven Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0000947871-25-000616 Size: 30 KB

Full text

Register to leave comments
There are no comments here yet...